ANIXA BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
ANIXA BIOSCIENCES, INC. (ANIX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $495.00 thousand for the 12-month period ending 2024-10-31, per its 10-K filed 2025-01-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2025-01-10
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2024 was $495.00K, a 65.53% decline from fiscal 2023.
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2023 was $1.44M, a 41.84% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $2.47M, a 40.16% decline from fiscal 2021.
- ANIXA BIOSCIENCES, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2021 was $4.13M, a 72.20% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month as first filed |
|---|---|---|
| 2024-10-31 | $495.00K 10-K · filed 2025-01-10 | |
| 2023-10-31 | $1.44M 10-K · filed 2025-01-10 | |
| 2022-10-31 | $2.47M 10-K · filed 2024-01-16 | |
| 2021-10-31 | $4.13M 10-K · filed 2023-01-04 | |
| 2020-10-31 | $2.40M 10-K · filed 2022-01-04 | |
| 2019-10-31 | $1.55M 10-K · filed 2021-01-07 | |
| 2018-10-31 | $1.25M 10-K · filed 2020-01-09 | |
| 2012-10-31 | $63.00K 10-K/A · filed 2014-01-17 | $2.53M 10-K · filed 2013-01-29 |
| 2011-10-31 | $7.44M 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |